Protagenic Therapeutics Inc. — Form D
Protagenic Therapeutics Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2013-09-27. The offering totals $643K, of which $643K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-09-27
- Form: D
- Accession: 0001383099-13-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $643K
- Amount sold: $643K
- Investors: 5
- Date of first sale: 2013-02-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-203658
Issuer
- Name: Protagenic Therapeutics Inc.
- CIK: 0001383099
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 149 5TH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Phone: 1-416-500-3305
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Garo Armen | Director | Lexington, MA |
| Khalil Barrage | Director | Boston, MA |
| Hartoun Hartounian | Director | New York, NY |
| Robert Ziroyan | Executive Officer | New York, NY |
Other filings by this issuer (1)
More